Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2027

Publisher Name :
Date: 31-Jan-2018
No. of pages: 100
Price : Single User: US $ 6250  US $ 5000 Corporate User: US $ 18750  US $ 11250
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2018. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Crohn's Disease (CD) epidemiology and market outlook for the 7MM.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2027

Crohn's Disease (CD) Understanding and Treatment Algorithm

The market report provides the overview of the Crohn's Disease (CD) by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.

Crohn's Disease (CD) Epidemiology

The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2018 to 2027 segmented by seven major markets, enabling to understand the potential of the Crohn's Disease (CD) in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.

Crohn's Disease (CD) Product Profiles & Analysis

The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.

Crohn's Disease (CD) Market Outlook

The report's market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Crohn's Disease (CD) market.

Crohn's Disease (CD) Market Share by Therapies

This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2027. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.

Crohn's Disease (CD) Report Insights

- Patient Population in Crohn's Disease (CD)

- Therapeutic Approaches in Crohn's Disease (CD)

- Crohn's Disease (CD) Pipeline Analysis

- Crohn's Disease (CD) Market Size and Trends

- Crohn's Disease (CD) Market Opportunities

- Impact of upcoming Therapies in Crohn's Disease (CD)

Crohn's Disease (CD) Report Key Strengths

- 10 Year Forecast

- 7MM Coverage

- Epidemiology Segmentation

- Drugs Uptake

- Highly Analyzed Market

- Key Cross Competition

Crohn's Disease (CD) Report Assessment

- Current Treatment Practices in Crohn's Disease (CD)

- Unmet Needs in Crohn's Disease (CD)

- Market Attractiveness

- Market Drivers and Barriers

Key Benefits

- The report will help to develop Business Strategies by understanding the trends shaping and driving the Crohn's Disease (CD) market

- Organize sales and marketing efforts by identifying the best opportunities for Crohn's Disease (CD) market

- To understand the future market competition in the Crohn's Disease (CD) market.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2018. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2027

Table of Contents

1. Report Introduction
2. Crohn's Disease (CD) Market Overview at a Glance
2.1. Market Share Distribution of Crohn's Disease (CD) in 2017
2.2. Market Share Distribution of Crohn's Disease (CD) in 2027
3. Disease Background and Overview: Crohn's Disease (CD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Crohn's Disease (CD) in 7MM
4.3. Total Prevalent Patient Population of Crohn's Disease (CD) in 7MM - By Countries
5. Epidemiology of Crohn's Disease (CD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.1.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.1.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.1.5. Diagnosed Cases of the Crohn's Disease (CD)
5.1.6. Treatable Cases of the Crohn's Disease (CD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.4.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.4.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.4.5. Diagnosed Cases of the Crohn's Disease (CD)
5.4.6. Treatable Cases of the Crohn's Disease (CD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.5.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.5.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.5.5. Diagnosed Cases of the Crohn's Disease (CD)
5.5.6. Treatable Cases of the Crohn's Disease (CD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.6.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.6.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.6.5. Diagnosed Cases of the Crohn's Disease (CD)
5.6.6. Treatable Cases of the Crohn's Disease (CD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.7.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.7.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.7.5. Diagnosed Cases of the Crohn's Disease (CD)
5.7.6. Treatable Cases of the Crohn's Disease (CD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.8.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.8.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.8.5. Diagnosed Cases of the Crohn's Disease (CD)
5.8.6. Treatable Cases of the Crohn's Disease (CD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Crohn's Disease (CD)
5.9.3. Sub-Type Specific cases of the Crohn's Disease (CD) *
5.9.4. Sex- Specific Cases of the Crohn's Disease (CD) *
5.9.5. Diagnosed Cases of the Crohn's Disease (CD)
5.9.6. Treatable Cases of the Crohn's Disease (CD)
6. Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Crohn's Disease (CD)
8. Marketed Therapies
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies - At a glance
10. Key Cross Competition
11. Emerging Therapies for Crohn's Disease (CD)
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Crohn's Disease (CD) : 7MM Market Analysis
12.1. 7MM Market Size of Crohn's Disease (CD)
12.2. 7MM Percentage Share of drugs marketed for Crohn's Disease (CD)
12.3. 7MM Market Sales of Crohn's Disease (CD) by Products
13. Crohn's Disease (CD) : Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Crohn's Disease (CD) in United States
13.1.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in United States
13.1.3. Market Sales of Crohn's Disease (CD) by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Crohn's Disease (CD) in Germany
13.2.1.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in Germany
13.2.1.3. Market Sales of Crohn's Disease (CD) by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Crohn's Disease (CD) in France
13.2.2.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in France
13.2.2.3. Market Sales of Crohn's Disease (CD) by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Crohn's Disease (CD) in Italy
13.2.3.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in Italy
13.2.3.3. Market Sales of Crohn's Disease (CD) by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Crohn's Disease (CD) in Spain
13.2.4.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in Spain
13.2.4.3. Market Sales of Crohn's Disease (CD) by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Crohn's Disease (CD) in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in United Kingdom
13.2.5.3. Market Sales of Crohn's Disease (CD) by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Crohn's Disease (CD) in Japan
13.3.2. Percentage Share of drugs marketed for Crohn's Disease (CD) in Japan
13.3.3. Market Sales of Crohn's Disease (CD) by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Crohn's Disease (CD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Crohn's Disease (CD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Crohn's Disease (CD) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Crohn's Disease (CD) in United States (2016-2027)
Table 5: Sex- Specific Cases of the Crohn's Disease (CD) in United States (2016-2027)
Table 6: Diagnosed Cases of the Crohn's Disease (CD) in United States (2016-2027)
Table 7: Treatable Cases of the Crohn's Disease (CD) in United States (2016-2027)
Table 8: Prevalent/Incident Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Table 9: Sub-Type Specific cases of the Crohn's Disease (CD) in Germany (2016-2027)
Table 10: Sex- Specific Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Table 11: Diagnosed Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Table 12: Treatable Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Table 13: Prevalent/Incident Cases of the Crohn's Disease (CD) in France (2016-2027)
Table 14: Sub-Type Specific cases of the Crohn's Disease (CD) in France (2016-2027)
Table 15: Sex- Specific Cases of the Crohn's Disease (CD) in France (2016-2027)
Table 16: Diagnosed Cases of the Crohn's Disease (CD) in France (2016-2027)
Table 17: Treatable Cases of the Crohn's Disease (CD) in France (2016-2027)
Table 18: Prevalent/Incident Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Table 19: Sub-Type Specific cases of the Crohn's Disease (CD) in Italy (2016-2027)
Table 20: Sex- Specific Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Table 21: Diagnosed Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Table 22: Treatable Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Table 23: Prevalent/Incident Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Table 24: Sub-Type Specific cases of the Crohn's Disease (CD) in Spain (2016-2027)
Table 25: Sex- Specific Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Table 26: Diagnosed Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Table 27: Treatable Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Table 28: Prevalent/Incident Cases of the Crohn's Disease (CD) in UK (2016-2027)
Table 29: Sub-Type Specific cases of the Crohn's Disease (CD) in UK (2016-2027)
Table 30: Sex- Specific Cases of the Crohn's Disease (CD) in UK (2016-2027)
Table 31: Diagnosed Cases of the Crohn's Disease (CD) in UK (2016-2027)
Table 32: Treatable Cases of the Crohn's Disease (CD) in UK (2016-2027)
Table 33: Prevalent/Incident Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Table 34: Sub-Type Specific cases of the Crohn's Disease (CD) in Japan (2016-2027)
Table 35: Sex- Specific Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Table 36: Diagnosed Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Table 37: Treatable Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 42:7MM- Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 43:7MM- Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 44: United States-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 45: United States-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 46: United States-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 47: Germany-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 48: Germany-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 49: Germany-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 50: France-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 51: France-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 52: France-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 53: Italy-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 54: Italy-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 55: Italy-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 56: Spain-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 57: Spain-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 58: Spain-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 59:UK-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 60:UK-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 61:UK-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 62: Japan-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Table 63: Japan-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Table 64: Japan-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Crohn's Disease (CD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Crohn's Disease (CD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Crohn's Disease (CD) in United States (2016-2027)
Figure 4: Sub-Type Specific cases of the Crohn's Disease (CD) in United States (2016-2027)
Figure 5: Sex- Specific Cases of the Crohn's Disease (CD) in United States (2016-2027)
Figure 6: Diagnosed Cases of the Crohn's Disease (CD) in United States (2016-2027)
Figure 7: Treatable Cases of the Crohn's Disease (CD) in United States (2016-2027)
Figure 8: Prevalent/Incident Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Figure 9: Sub-Type Specific cases of the Crohn's Disease (CD) in Germany (2016-2027)
Figure 10: Sex- Specific Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Figure 11: Diagnosed Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Figure 12: Treatable Cases of the Crohn's Disease (CD) in Germany (2016-2027)
Figure 13: Prevalent/Incident Cases of the Crohn's Disease (CD) in France (2016-2027)
Figure 14: Sub-Type Specific cases of the Crohn's Disease (CD) in France (2016-2027)
Figure 15: Sex- Specific Cases of the Crohn's Disease (CD) in France (2016-2027)
Figure 16: Diagnosed Cases of the Crohn's Disease (CD) in France (2016-2027)
Figure 17: Treatable Cases of the Crohn's Disease (CD) in France (2016-2027)
Figure 18: Prevalent/Incident Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Figure 19: Sub-Type Specific cases of the Crohn's Disease (CD) in Italy (2016-2027)
Figure 20: Sex- Specific Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Figure 21: Diagnosed Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Figure 22: Treatable Cases of the Crohn's Disease (CD) in Italy (2016-2027)
Figure 23: Prevalent/Incident Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Figure 24: Sub-Type Specific cases of the Crohn's Disease (CD) in Spain (2016-2027)
Figure 25: Sex- Specific Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Figure 26: Diagnosed Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Figure 27: Treatable Cases of the Crohn's Disease (CD) in Spain (2016-2027)
Figure 28: Prevalent/Incident Cases of the Crohn's Disease (CD) in UK (2016-2027)
Figure 29: Sub-Type Specific cases of the Crohn's Disease (CD) in UK (2016-2027)
Figure 30: Sex- Specific Cases of the Crohn's Disease (CD) in UK (2016-2027)
Figure 31: Diagnosed Cases of the Crohn's Disease (CD) in UK (2016-2027)
Figure 32: Treatable Cases of the Crohn's Disease (CD) in UK (2016-2027)
Figure 33: Prevalent/Incident Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Figure 34: Sub-Type Specific cases of the Crohn's Disease (CD) in Japan (2016-2027)
Figure 35: Sex- Specific Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Figure 36: Diagnosed Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Figure 37: Treatable Cases of the Crohn's Disease (CD) in Japan (2016-2027)
Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 42:7MM- Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 43:7MM- Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 44: United States-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 45: United States-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 46: United States-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 47: Germany-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 48: Germany-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 49: Germany-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 50: France-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 51: France-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 52: France-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 53: Italy-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 54: Italy-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 55: Italy-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 56: Spain-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 57: Spain-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 58: Spain-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 59:UK-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 60:UK-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 61:UK-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 62: Japan-Market Size of Crohn's Disease (CD) in USD MM (2016-2027)
Figure 63: Japan-Market Share Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
Figure 64: Japan-Market Sales of Crohn's Disease (CD) by Therapies in USD MM (2016-2027)
  • Global Crohn's Disease Drug Market Insights, Forecast to 2025
    Published: 31-Oct-2018        Price: US 3900 Onwards        Pages: 114
    This report studies the global market size of Crohn's Disease Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Crohn's Disease Drug in these regions. This research report categorizes the global Crohn's Disease Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market driver......
  • Global Crohn's Disease Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the Chrohn's disease partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Crohn's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top ......
  • Global Crohn?s Disease Drug Market Data Survey Report 2025
    Published: 07-Aug-2018        Price: US 1500 Onwards        Pages: 63
    Summary The global Crohn?s Disease Drug market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Average market price by SUK Major applications Key manufacturers are included based on manufacturi......
  • 2015-2023 World Crohn?s Disease Drug Market Research Report by Product Type, End-User (Application) and Regions (Countries)
    Published: 16-Jun-2018        Price: US 2800 Onwards        Pages: 109
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc) - Middle East & Afri......
  • Global and China Crohn?s Disease Drug Market Research by Company, Type & Application 2013-2025
    Published: 25-May-2018        Price: US 2000 Onwards        Pages: 81
    Summary Market Segment as follows: By Type - Aminosalicylates (5-ASA) - Corticosteroids - Immunomodulators - Antibiotics By Application - Achieving Remission (The Absence Of Symptoms) - Maintaining Remission (Prevention Of Flare-Ups) - Pediatric Crohn'S Disease By Company - AbbVie - Janssen Biotech - UCB - Amgen - Tillotts Pharma - Takeda Pharmac......
  • Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018
    Published: 20-Feb-2018        Price: US 2000 Onwards        Pages: 408
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn's Disease (Regional Enteritis) (Gastrointestinal) pipeline landscape. Crohn's disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of digestive tract, which can lead to abdominal pain, severe diarrhea and even malnutrition. Inflammation caused by Crohn's disease can inv......
  • Crohn's Disease (CD) - Epidemiology Forecast to 2027
    Published: 31-Jan-2018        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Crohn's Disease (CD) - Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Crohn's Disease (CD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Crohn's Disease (CD) Epidemiology The epidemiology......
  • Cimzia - Drug Insights
    Published: 31-Jan-2018        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Cimzia Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Cimzia covering the historical global sales and also provides the Cimzia sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, mar......
  • Entyvio - Drug Insights
    Published: 31-Jan-2018        Price: US 1000 Onwards        Pages: 35
    Introduction DelveInsight's pharmaceuticals report, "Entyvio Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Entyvio covering the historical global sales and also provides the Entyvio sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs